With the contribution from more than one hundred CNS neurotrauma experts, this book
provides a comprehensive and up-to-date account on the latest developments in the area of …

Mild traumatic brain injury (mTBI) is a common health problem. There is tremendous
variability and heterogeneity in human mTBI, including mechanisms of injury, biomechanical …

Neurological dysfunction after traumatic brain injury (TBI) is caused by both the primary
injury and a secondary cascade of biochemical and metabolic events. Since TBI can be …

Background Traumatic brain injury (TBI) initiates a complex series of neurochemical and
signaling changes that lead to pathological events including neuronal hyperactivity …

Traumatic brain injury (TBI) results in both rapid and delayed brain damage. The speed,
complexity, and persistence of TBI present large obstacles to drug development. Preclinical …

Background No new therapies for traumatic brain injury (TBI) have been officially translated
into current practice. At the tissue and cellular level, both inflammatory and oxidative …

Traumatic brain injury (TBI) differs in severity from severe to mild. This study examined
whether a combination of the drugs minocycline (MINO) plus N-acetylcysteine (NAC) …

The majority of people who sustain a traumatic brain injury (TBI) have an injury that can be
classified as mild (often referred to as concussion). Although head CT scans for most …

Background There are no drugs presently available to treat traumatic brain injury (TBI). A
variety of single drugs have failed clinical trials suggesting a role for drug combinations …

A majority of traumatic brain injuries (TBI) in motor vehicle crashes and sporting
environments are mild and caused by high-rate acceleration of the head. For injuries caused …